View source for Phase III research associated with adjuvant gemcitabine compared with adjuvant uraciltegafur in individuals with entirely resected pathological point IBIIIA nonsmall mobile carcinoma of the lung WJTOG0101
From EECH Central
You do not have permission to edit this page, for the following reasons:
You can view and copy the source of this page.